Table 1.
Summary of the Demographic Parameters of the Study Patients
| Ocular | No. of Anti- | Systemic | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Patient No. | Age | DM Type | DM Duration | HbA1c in % | DR Stage | BCVA | Pretreatment | VEGF Injections | Disease |
| 1 | 58 | II | 2 y | 7.5 | Moderate | 20/32 | Anti-VEGF | 9 | Hypertension |
| 2 | 34 | I | 22 y | 7.3 | Moderate | 25/20 | Non | – | Non |
| 3 | 38 | I | 34 y | 7.1 | Quiescent proliferative | 20/20 | PRP | – | Non |
| 4 | 60 | II | 7 y | 7.6 | Active proliferative | 20/40 | Anti-VEGF | 5 | Hypertension |
DM = diabetes mellitus, DR = diabetic retinopathy, BCVA = best-corrected visual acuity, No. = number.